Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Irving GJ, Holden J, Yang R, Pope D.

Cochrane Database Syst Rev. 2019 Dec 17;12:CD009051. doi: 10.1002/14651858.CD009051.pub3. Review.

PMID:
31846062
2.

Statin therapy does not influence the outcome of patients undergoing surgery for pancreatic cancer.

Karavias D, Thomas P, Koh A, Irving G, Navarro AP, Cameron IC, Gomez D; Nottingham HPB Surgery Group.

ANZ J Surg. 2019 Dec 17. doi: 10.1111/ans.15600. [Epub ahead of print]

PMID:
31845479
3.

Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.

Griffin SJ, Rutten GEHM, Khunti K, Witte DR, Lauritzen T, Sharp SJ, Dalsgaard EM, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, Sandbæk A.

Lancet Diabetes Endocrinol. 2019 Dec;7(12):925-937. doi: 10.1016/S2213-8587(19)30349-3.

PMID:
31748169
4.

Building primary care in Japan: Literature review.

Kato D, Ryu H, Matsumoto T, Abe K, Kaneko M, Ko M, Irving G, Ramsay R, Kondo M.

J Gen Fam Med. 2019 May 13;20(5):170-179. doi: 10.1002/jgf2.252. eCollection 2019 Sep. Review.

5.

Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study.

Dambha-Miller H, Day AJ, Strelitz J, Irving G, Griffin SJ.

Diabet Med. 2020 Apr;37(4):681-688. doi: 10.1111/dme.14122. Epub 2019 Sep 26.

PMID:
31479535
6.

C-reactive Protein is an Independent Predictor of Difficult Emergency Cholecystectomy.

Gregory GC, Kuzman M, Sivaraj J, Navarro AP, Cameron IC, Irving G, Gomez D.

Cureus. 2019 Apr 30;11(4):e4573. doi: 10.7759/cureus.4573.

7.

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.

Howells LM, Iwuji COO, Irving GRB, Barber S, Walter H, Sidat Z, Griffin-Teall N, Singh R, Foreman N, Patel SR, Morgan B, Steward WP, Gescher A, Thomas AL, Brown K.

J Nutr. 2019 Jul 1;149(7):1133-1139. doi: 10.1093/jn/nxz029.

8.

Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.

Strelitz J, Ahern AL, Long GH, Hare MJL, Irving G, Boothby CE, Wareham NJ, Griffin SJ.

Diabetologia. 2019 Aug;62(8):1391-1402. doi: 10.1007/s00125-019-4886-1. Epub 2019 May 7.

9.

The day we met Julian Tudor Hart.

Irving G, Holden J.

Br J Gen Pract. 2018 Sep;68(674):415. doi: 10.3399/bjgp18X698501. No abstract available.

10.

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.

Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies M, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M, Sattar N, Sharp S.

Health Technol Assess. 2018 Apr;22(18):1-64. doi: 10.3310/hta22180.

11.

Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study.

Boyd-Carson H, Irving G, Navarro AP, Cameron IC, Gomez DS; Nottingham HPB Surgery Group.

Int J Surg. 2018 May;53:59-64. doi: 10.1016/j.ijsu.2018.03.031. Epub 2018 Mar 16.

PMID:
29555531
12.

Patients' views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years.

Dambha-Miller H, Silarova B, Irving G, Kinmonth AL, Griffin SJ.

Br J Gen Pract. 2018 Jan;68(666):e36-e43. doi: 10.3399/bjgp17X693917. Epub 2017 Dec 4.

13.

International variations in primary care physician consultation time: a systematic review of 67 countries.

Irving G, Neves AL, Dambha-Miller H, Oishi A, Tagashira H, Verho A, Holden J.

BMJ Open. 2017 Nov 8;7(10):e017902. doi: 10.1136/bmjopen-2017-017902. Review.

14.

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.

Griffin SJ, Leaver JK, Irving GJ.

Diabetologia. 2017 Sep;60(9):1620-1629. doi: 10.1007/s00125-017-4337-9. Epub 2017 Aug 2. Review.

15.

Should we screen for atrial fibrillation?

Lown M, Garrard J, Irving G, Edwards D, Hobbs FR, Mant J.

Br J Gen Pract. 2017 Jul;67(660):296-297. doi: 10.3399/bjgp17X691613. No abstract available.

16.

RETRACTION:  How blockchain-timestamped protocols could improve the trustworthiness of medical science.

Irving G, Holden J.

F1000Res. 2017 Jun 8;6:805. doi: 10.12688/f1000research.11888.1. eCollection 2017.

17.

Diallyl trisulfide attenuated n-hexane induced neurotoxicity in rats by modulating P450 enzymes.

Wang S, Li M, Wang X, Li X, Yin H, Jiang L, Han W, Irving G, Zeng T, Xie K.

Chem Biol Interact. 2017 Mar 1;265:1-7. doi: 10.1016/j.cbi.2017.01.013. Epub 2017 Jan 20.

PMID:
28115069
18.

The ecology of medical care on an isolated island in Okinawa, Japan: a retrospective open cohort study.

Kaneko M, Matsushima M, Irving G.

BMC Health Serv Res. 2017 Jan 14;17(1):37. doi: 10.1186/s12913-017-1979-8.

19.

Oxidative Stress Mediated Hippocampal Neuron Apoptosis Participated in Carbon Disulfide-Induced Rats Cognitive Dysfunction.

Wang S, Irving G, Jiang L, Wang H, Li M, Wang X, Han W, Xu Y, Yang Y, Zeng T, Song F, Zhao X, Xie K.

Neurochem Res. 2017 Feb;42(2):583-594. doi: 10.1007/s11064-016-2113-8. Epub 2016 Nov 29.

PMID:
27900598
20.

Which cuff should I use? Indirect blood pressure measurement for the diagnosis of hypertension in patients with obesity: a diagnostic accuracy review.

Irving G, Holden J, Stevens R, McManus RJ.

BMJ Open. 2016 Nov 3;6(11):e012429. doi: 10.1136/bmjopen-2016-012429. Review.

21.

Interventions to increase or decrease the length of primary care physicians' consultation.

Wilson AD, Childs S, Gonçalves-Bradley DC, Irving GJ.

Cochrane Database Syst Rev. 2016 Aug 25;(8):CD003540. doi: 10.1002/14651858.CD003540.pub3. Review.

PMID:
27560697
22.

After Achilles.

Irving G, Holden J.

Br J Gen Pract. 2016 May;66(646):238. doi: 10.3399/bjgp16X684913. No abstract available.

23.

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.

Hermanowicz N, Ellenbogen A, Irving G, Buchfuhrer M, Jaros MJ, Shang G, Kim R.

CNS Drugs. 2016 May;30(5):443-54. doi: 10.1007/s40263-016-0333-8.

PMID:
27095237
24.

The AGREE Reporting Checklist is useful for assessing the quality of clinical practice guideline development.

Irving G.

BMJ. 2016 Apr 12;353:i2027. doi: 10.1136/bmj.i2027. No abstract available.

PMID:
27071697
25.

How blockchain-timestamped protocols could improve the trustworthiness of medical science.

Irving G, Holden J.

Version 3. F1000Res. 2016 Feb 26 [revised 2017 Jan 1];5:222. doi: 10.12688/f1000research.8114.3. eCollection 2016. Retraction in: F1000Res. 2017 Jun 8;6:805.

26.

Pharmacological agents for the prevention of vestibular migraine.

Maldonado Fernández M, Birdi JS, Irving GJ, Murdin L, Kivekäs I, Strupp M.

Cochrane Database Syst Rev. 2015 Jun 21;(6):CD010600. doi: 10.1002/14651858.CD010600.pub2. Review.

27.

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.

James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR, Morgan B, Dennison A, Metcalfe M, Garcea G, Lloyd DM, Berry DP, Steward WP, Howells LM, Brown K.

Cancer Lett. 2015 Aug 10;364(2):135-41. doi: 10.1016/j.canlet.2015.05.005. Epub 2015 May 12.

28.

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.

Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM.

Trials. 2015 Mar 24;16:110. doi: 10.1186/s13063-015-0641-1.

29.

The meaning of suffering in patients with advanced progressive cancer.

Ellis J, Cobb M, O'Connor T, Dunn L, Irving G, Lloyd-Williams M.

Chronic Illn. 2015 Sep;11(3):198-209. doi: 10.1177/1742395314565720. Epub 2015 Jan 30.

PMID:
25637944
30.

[SBU report "misses" persuasive evidence. Dietary supplements extends the life of malnourished elderly].

Cederholm T, Bosaeus I, Brummer R, Ellegård L, Irving GF, Larsson J, Thorell A, Rothenberg E.

Lakartidningen. 2014 Dec 16;111(51-52):2299-300. Swedish. No abstract available.

31.

Colchicine for pericarditis.

Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A.

Cochrane Database Syst Rev. 2014 Aug 28;(8):CD010652. doi: 10.1002/14651858.CD010652.pub2. Review.

PMID:
25164988
32.

[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease].

Stenvinkel P, Irving GF, Wegener S, Eyre S, Rippe B, Segelmark M, Barany P, Samuelsson O.

Lakartidningen. 2014 Jul 2-15;111(27-28):1176-9. Review. Swedish. No abstract available.

33.

Cardiovascular disease and cancer compete for the outcome of death.

Irving G.

BMJ. 2014 Aug 19;349:g5227. doi: 10.1136/bmj.g5227. No abstract available.

PMID:
25138108
34.

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.

Irving G, Tanenberg RJ, Raskin J, Risser RC, Malcolm S.

Int J Clin Pract. 2014 Sep;68(9):1130-40. doi: 10.1111/ijcp.12452. Epub 2014 May 18.

PMID:
24837444
35.

Examining the practice of generalist expertise: a qualitative study identifying constraints and solutions.

Reeve J, Dowrick CF, Freeman GK, Gunn J, Mair F, May C, Mercer S, Palmer V, Howe A, Irving G, Shiner A, Watson J.

JRSM Short Rep. 2013 Nov 21;4(12):2042533313510155. doi: 10.1177/2042533313510155. eCollection 2013 Dec.

36.

From patient uncertainty to WHO policy in two years: a GP's experience of preparing and maintaining a Cochrane review.

Irving G.

Eur J Gen Pract. 2014 Mar;20(1):74-7. doi: 10.3109/13814788.2013.828689. Epub 2013 Nov 6.

PMID:
24195593
37.

Global health: time for full integration into GP education.

Watson J, Shiner A, Pettigrew LM, Irving G.

Br J Gen Pract. 2013 May;63(610):271-2. doi: 10.3399/bjgp13X667358. No abstract available.

38.

Measures of promptness of cancer diagnosis in primary care.

Irving G, Holden J.

Br J Cancer. 2013 May 28;108(10):2186. doi: 10.1038/bjc.2013.193. Epub 2013 May 2. No abstract available.

39.

The John Henry effect.

Irving G, Holden J.

BMJ. 2013 Apr 2;346:f1804. doi: 10.1136/bmj.f1804. No abstract available.

PMID:
23550069
40.

The time-efficiency principle: time as the key diagnostic strategy in primary care.

Irving G, Holden J.

Fam Pract. 2013 Aug;30(4):386-9. doi: 10.1093/fampra/cmt007. Epub 2013 Mar 27.

41.

Chronic heart failure guidelines: do they adequately address patient need at the end-of-life?

Irving G, Holden J, Edwards J, Reeve J, Dowrick C, Lloyd-Williams M.

Int J Cardiol. 2013 Oct 3;168(3):2304-9. doi: 10.1016/j.ijcard.2013.01.189. Epub 2013 Mar 7. Review.

42.

Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.

Jensen MP, Irving G, Rauck R, Wallace M, Sweeney M, Vanhove GF.

Clin J Pain. 2013 Sep;29(9):770-4. doi: 10.1097/AJP.0b013e31827b32ab.

PMID:
23370075
43.

Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.

Irving G.

Ther Adv Chronic Dis. 2012 Sep;3(5):211-8. doi: 10.1177/2040622312452905.

44.

Dismantling Lord Moran's ladder: the primary care expert generalist.

Reeve J, Irving G, Freeman G.

Br J Gen Pract. 2013 Jan;63(606):34-5. doi: 10.3399/bjgp13X660823. No abstract available.

45.

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability.

Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, Berry DP, Hemingway D, Miller AS, Brown K, Gescher AJ, Steward WP.

Cancer Prev Res (Phila). 2013 Feb;6(2):119-28. doi: 10.1158/1940-6207.CAPR-12-0281. Epub 2012 Dec 11.

46.

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

Rauck RL, Irving GA, Wallace MS, Vanhove GF, Sweeney M.

J Pain Symptom Manage. 2013 Aug;46(2):219-28. doi: 10.1016/j.jpainsymman.2012.07.011. Epub 2012 Nov 11.

47.

Global health in the UK's GP postgraduate curriculum.

Irving G, Riley B, Rughani A, Pettigrew L, Watson J, Shiner A, Hibble A, Allen J; Royal College of General Practitioners Curriculum Development Committee.

Lancet. 2012 Nov 10;380(9854):1646-7. doi: 10.1016/S0140-6736(12)61947-3. No abstract available.

PMID:
23141613
48.

Do GPs really provide 47 minutes a year for the patient?

Irving G, Reeve J.

Br J Gen Pract. 2012 Aug;62(601):404-5. doi: 10.3399/bjgp12X653499. No abstract available.

49.

Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia.

Irving GA, Sweeney M.

J Pain Res. 2012;5:203-8. doi: 10.2147/JPR.S32562. Epub 2012 Jun 25.

50.

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Irving GJ, Holden J, Yang R, Pope D.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009051. doi: 10.1002/14651858.CD009051.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Dec 17;12:CD009051.

Supplemental Content

Loading ...
Support Center